Two diabetes medications more beneficial in preventing major cardiovascular events
June 3, 2024 / GLP-1 / Diabetes / Heart Protection / Liver Complications
GLP-1 receptor agonists and SGLT-2 inhibitors reduce major cardiovascular events and severe liver complications in type 2 diabetes patients compared to other treatments, according to data presented at ENDO 2024.
Can you eat whatever you want after ‘reversing’ type 2 diabetes?
June 3, 2024 / Type 2 Diabetes / Insulin / Eating Habits
Even after reversing type 2 diabetes, maintaining a healthy diet is essential as returning to old eating patterns can lead to insulin resistance and recurrence, advises dietician Charmaine Ha Dominguez.
Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice
June 3, 2024 / Metabolic Syndrome / Obesity
Modified fecal virome transplants (FVTs) in obese male mice improved blood glucose clearance and metabolic syndrome symptoms without the risks associated with pathogenic microbes, highlighting potential benefits for metabolic disorder treatments.
Ozempic, Wegovy changes response to sweet tastes in females
June 3, 2024 / Ozempic / Wegovy /GLP-1
A study presented at ENDO 2024 found that semaglutide, the active ingredient in Ozempic and Wegovy, improves taste sensitivity to sweet flavors in obese women by modifying gene expression and brain response.
GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients
June 3, 2024 / GLP-1 / Diabetes / Obesity
GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in obese and diabetic patients compared to SGLT2 and DPP4 inhibitors, as presented at ENDO 2024.
Childhood inactivity linked to increased risk of liver disease by young adulthood
June 3, 2024 / Liver Disease / Fatty Liver Disease
Children sedentary for over six hours daily face a significantly higher risk of developing severe fatty liver disease and liver cirrhosis by young adulthood, according to a study presented at ENDO 2024.
Garlic proves potent in reducing blood sugar and cholesterol, study reveals
June 2, 2024 / Garlic / Cholesterol Lowering / metabolic Disease / Cardiovascular Health
A study found that garlic effectively reduces blood sugar and cholesterol levels, suggesting its potential as a natural treatment for metabolic diseases like diabetes and cardiovascular disorders.
Sex has unique health benefits for chronically stressed moms, study finds
June 2, 2024 / Sexual Health / Stress / Mental Health
Sexual activity helps chronically stressed mothers, particularly those with children on the autism spectrum, by improving metabolic hormone levels and reducing the risk of stress-related diseases, according to a new study.
Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study
June 2, 2024 / CKD Risk / Obesity / Kidney Disease / MAFLD Study
A national retrospective cohort study found that abdominal obesity and metabolic dysfunction-associated fatty liver disease (MAFLD) significantly increase the risk and mortality of chronic kidney disease (CKD), with abdominal obesity mediating this association more effectively than BMI.
Diabetes drug shows promise for aging-related illnesses in mice study
May 24, 2024 / Juntendo University / Diabetes / Aging / Alzheimer’s
A Juntendo University study found that an SGLT2 inhibitor diabetes drug can eliminate senescent cells in mice, potentially treating aging-related diseases like Alzheimer’s with minimal side effects.
Metabolic syndrome a scary epidemic that few can define
May 31, 2024 / Metabolic Syndrome / Health Risk
Metabolic syndrome, characterized by high blood sugar, fat, cholesterol, blood pressure, and abdominal obesity, increases the risk of heart disease, diabetes, stroke, and certain cancers. Despite affecting one-third of U.S. adults, it’s rarely diagnosed.
Breast Cancer linked to common health condition
May 31, 2024 / Obesity / Breat Cancer Risk / Metabolic Syndrome / Women’s Health
A study found that obesity increases breast cancer incidence, while a high metabolic syndrome score raises breast cancer mortality. A low-fat diet may reduce death rates, particularly in women with metabolic syndrome.
GLP-1 receptor agonists effective for weight loss in obesity without diabetes
May 29, 2024 / gLP-1 Receptor / Diabetes / Weight Loss / Diabetes
GLP-1 receptor agonists, originally for diabetes, effectively achieve 10% weight loss in non-diabetic obese individuals, outweighing potential harms, though benefits vary based on treatment goals and tolerance for side effects.
Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes
May 29, 2024 / Microplastics / Diabetes / Placenta Damage
A study on mice revealed that polystyrene microplastics disrupt glucose metabolism, increase insulin resistance, and damage the placenta during pregnancy, raising the risk of gestational diabetes and intrauterine death.
Intermittent fasting shows promise in improving gut health, weight management
May 29, 2024 / Intermittent Fasting / Gut Health / Weight Loss / Metabolic Benefits
An Arizona State University study found that intermittent fasting with protein pacing improves gut health, weight management, and metabolic responses better than simple calorie restriction in overweight individuals.
Fight against obesity goes far beyond individual struggle to change lifestyle, scientists say
May 29, 2024 / Anti-Obesity / Ozempic / Obesity
Anti-obesity drugs like Ozempic were highlighted as a major breakthrough in 2023. However, scientists stress that addressing obesity requires multidisciplinary approaches beyond individual lifestyle changes, considering significant socioeconomic and environmental factors.
A New Way To Treat Obesity? UV Light Found To Prevent Body Weight Gain
May 29, 2024 / UV Light / Obesity Treatment / Weight Management / Hormone Regulation
UV exposure influences appetite and weight management by altering hormone levels and converting white fat to brown fat, potentially offering new obesity treatments, according to research published in the Journal of Investigative Dermatology.
Study links low oxytocin levels to symptoms of polycystic ovary syndrome
May 23, 2024 / Low Oxytocin / PCOS / Fertility Issues / Weight Management
A study in Current Issues in Molecular Biology found that women with polycystic ovary syndrome (PCOS) have reduced oxytocin levels, which are linked to fertility issues and weight problems, suggesting oxytocin’s potential role in PCOS development.